🚀
Enjoy a 7-Day Free Trial Thru Jan 12, 2025!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Canadian Insider
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Medical Diagnostics & Research
Myriad Genetics Inc (LTS:0K3W)
News
Myriad Genetics Inc
LTS
:0K3W (USA) Â
Ordinary Shares
$ 13.64
(+2.19%)
Jan 3
P/E:
At Loss
P/B:
1.70
Market Cap:
$ 1.24B
Enterprise V:
$ 1.29B
Volume:
20.00
Avg Vol (2M):
828.00
Warning! GuruFocus detected 3 Severe warning signs with 0K3W.
Try a 7-Day Free Trial
to check it out.
Trade In:
Volume:
20.00
Market Cap $:
1.24B
PE Ratio:
At Loss
Avg Vol (2M):
828.00
Enterprise Value $:
1.29B
PB Ratio:
1.70
Alerts
Website
Sources
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Myriad Genetics Inc (LTS:0K3W) Stock News, Headlines & Updates
Myriad Genetics Inc Stock News from GuruFocus
Total 38
1
Dec 19, 2024
Myriad Genetics Inc (MYGN) Unveils Study Highlighting RiskScore's Superior Accuracy in Predicting Breast Cancer Risk
GuruFocus News
•
4:03pm
Myriad Genetics' RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
Marketwired
•
4:00pm
Dec 12, 2024
Myriad Genetics (MYGN) Stock Surges 5% Amid Market Activity
GuruFocus News
•
2:34pm
Dec 11, 2024
Myriad Genetics Inc (MYGN) Engages with UnitedHealthcare Over GeneSight Test Policy
GuruFocus News
•
6:08pm
Myriad Genetics Provides Update on Discussions with UnitedHealthcare regarding Medical Policy for Pharmacogenetic Testing
Marketwired
•
6:00pm
Dec 10, 2024
Myriad Genetics Inc (MYGN) Expands Board with Appointment of Mark S. Davis
GuruFocus News
•
4:02pm
Myriad Genetics Expands Board of Directors with Election of Mark S. Davis as New Board Member
Marketwired
•
4:00pm
Myriad Genetics' Portfolio Elevated by Updated NCCN Prostate Cancer Guidelines
Marketwired
•
7:00am
Dec 09, 2024
Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium
Marketwired
•
4:00pm
NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an 'Advanced Tool' Recommended for Prognostic Assessment
Marketwired
•
7:00am
Dec 04, 2024
Myriad Genetics Inc (MYGN) Stock Price Up 3.33% on Dec 4
GuruFocus News
•
11:03am
Nov 20, 2024
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina's Updated Comprehensive Gene Panel Assay, TruSightâ„¢ Oncology 500 v2
Marketwired
•
4:00pm
Nov 19, 2024
Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy
Marketwired
•
7:00am
Nov 17, 2024
MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
Marketwired
•
3:00pm
Nov 14, 2024
MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
Business Wire
•
4:00pm
Nov 13, 2024
MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
PRNewswire
•
4:00pm
Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch
Marketwired
•
7:00am
Nov 12, 2024
Myriad Genetics Inc (MYGN) Shares Gap Down to $16.76 on Nov 12
GuruFocus News
•
10:07am
Nov 11, 2024
MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
Marketwired
•
3:00pm
Nov 08, 2024
Myriad Genetics Inc (MYGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Policy Challenges
GuruFocus News
•
1:26am
Q3 2024 Myriad Genetics Inc Earnings Call Transcript
GuruFocus News
•
11:25pm
Nov 07, 2024
Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance
Marketwired
•
4:00pm
MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
Business Wire
•
4:00pm
Myriad Genetics Inc Reports Q3 2024 Revenue of $213 Million, Beating Estimates; GAAP EPS Improves to $(0.24)
GuruFocus News
•
3:53pm
Nov 06, 2024
MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
PRNewswire
•
4:00am
Nov 05, 2024
MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
Marketwired
•
3:00pm
Nov 04, 2024
Myriad Genetics Inc (MYGN) Trading Down 3.81% on Nov 4
GuruFocus News
•
10:09am
Myriad Genetics Comments on UnitedHealthcare's Updated Medical Policy for Pharmacogenetic Testing
Marketwired
•
8:00am
Nov 01, 2024
Myriad Genetics Inc (MYGN) Shares Gap Down to $17.395 on Nov 1
GuruFocus News
•
11:11am
Oct 30, 2024
Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024
Marketwired
•
7:00am
Oct 21, 2024
Myriad Genetics Inc (MYGN) Shares Down 3.46% on Oct 21
GuruFocus News
•
12:01pm
Oct 16, 2024
Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access
Marketwired
•
8:00am
Oct 15, 2024
Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration
Marketwired
•
8:00am
Oct 14, 2024
Myriad Genetics Inc (MYGN) Shares Up 3.14% on Oct 14
GuruFocus News
•
12:01pm
Oct 12, 2024
Insider Sale: President and CEO Paul Diaz Sells 15,000 Shares of Myriad Genetics Inc (MYGN)
GuruFocus News
•
7:04pm
Oct 10, 2024
MYGN Stock Drops 5% Amidst Market Movements in Life Sciences Sector
GuruFocus News
•
2:31pm
Oct 09, 2024
Myriad Genetics Inc (MYGN) Trading Down 4.78% on Oct 9
GuruFocus News
•
11:03am
Oct 08, 2024
Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer
Marketwired
•
4:00pm
Total 38
1
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news